Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders

Current Behavioral Neuroscience Reports
Sara CostiJames W Murrough

Abstract

Major Depressive Disorder (MDD) is a leading cause of disability worldwide. Despite a plethora of established treatments, less than one-third of individuals with MDD achieve stable remission of symptoms. Given limited efficacy and significant lag time to onset of therapeutic action among conventional antidepressants, interest has shifted to treatments that act outside of the monoamine neurotransmitter systems (e.g., serotonin, norepinephrine, and dopamine). Preclinical and clinical research on the glutamate system has been particularly promising in this regard. Accumulating evidence shows support for a rapid antidepressant effect of ketamine - a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist. The present article reviews the pharmacology, safety, and efficacy of ketamine as a novel therapeutic agent for mood and anxiety disorders. The majority of clinical trials using ketamine have been conducted in patients with treatment resistant forms of MDD; recent work has begun to examine ketamine in bipolar disorder, posttraumatic stress disorder, and obsessive-compulsive disorder. The impact of ketamine on suicidal ideation is also discussed. The current status and prospects for the identification of human biomarkers of ketam...Continue Reading

References

Feb 1, 1985·British Journal of Anaesthesia·P F WhiteA J Trevor
Nov 1, 1993·The American Journal of Psychiatry·C A AltamuraF Zamberlan
Sep 4, 1999·Anesthesia and Analgesia·T KawasakiA Shigematsu
Feb 25, 2000·Biological Psychiatry·R M BermanJ H Krystal
Apr 4, 2000·Biological Psychiatry·J LevineJ W Pettegrew
Jul 29, 2000·Schizophrenia Research·E F TorreyR H Yolken
Jan 16, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David A Lewis
Jul 9, 2004·Archives of General Psychiatry·Gerard SanacoraGraeme F Mason
Jan 5, 2006·The American Journal of Psychiatry·Madhukar H TrivediUNKNOWN STAR*D Study Team
May 19, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hideaki MitaniRyuzou Kawahara
Aug 9, 2006·Archives of General Psychiatry·Carlos A ZarateHusseini K Manji
Sep 14, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael LiebrenzAlain Borgeat
Dec 13, 2007·Nature Reviews. Neuroscience·Robert DantzerKeith W Kelley
Apr 22, 2008·Nature Reviews. Drug Discovery·Gerard SanacoraHusseini K Manji
Nov 11, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anteneh M FeyissaBeata Karolewicz
Jan 20, 2009·Biological Psychiatry·Andrew H MillerCharles L Raison
Jun 2, 2009·Brain Research Reviews·Kenji Hashimoto
Oct 20, 2009·Trends in Pharmacological Sciences·Phil SkolnickRamon Trullas
Nov 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Bradley N GaynesA John Rush
Nov 10, 2009·Biological Psychiatry·Marije aan het RotSanjay J Mathew
Nov 13, 2009·The Journal of Clinical Psychiatry·Gerard Sanacora
Dec 18, 2009·Biological Psychiatry·Yekta DowlatiKrista L Lanctôt
Mar 15, 2011·European Archives of Psychiatry and Clinical Neuroscience·Laura KranasterAlexander Sartorius
May 12, 2011·The International Journal of Neuropsychopharmacology·Gregory Luke Larkin, Annette L Beautrais
Sep 6, 2011·Pharmacology, Biochemistry, and Behavior·Mark J NiciuGerard Sanacora
Feb 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lobna IbrahimCarlos A Zarate
Feb 7, 2012·CNS Drugs·Sanjay J MathewJames W Murrough
Jul 13, 2012·Biological Psychiatry·Michael H BlochChristopher Pittenger
Aug 1, 2012·The Journal of ECT·Chadi G AbdallahRobert Ostroff
Aug 4, 2012·Journal of Affective Disorders·Colleen K LooRoss Mac-Pherson
Aug 9, 2012·Journal of Affective Disorders·Wallace C DuncanCarlos A Zarate

❮ Previous
Next ❯

Citations

Jan 24, 2019·The New England Journal of Medicine·J A Jeevendra MartynEdward A Bittner
May 8, 2018·Harvard Review of Psychiatry·Sarah R Horn, Adriana Feder
Jun 5, 2016·Brain Research Bulletin·Yu LiuWenhua Zhou
Sep 19, 2018·Neuropharmacology·Georgina Perez-GarciaGregory A Elder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.